Wang, C. Y., Guo, S. T., Wang, J. Y., Yan, X. G., Farrelly, M., Zhang, Y. Y., . . . Jiang, C. C. (2016). Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. Oncotarget.
Chicago-stil citatWang, Chun Yan, et al. "Reactivation of ERK and Akt Confers Resistance of Mutant BRAF Colon Cancer Cells to the HSP90 Inhibitor AUY922." Oncotarget 2016.
MLA-referensWang, Chun Yan, et al. "Reactivation of ERK and Akt Confers Resistance of Mutant BRAF Colon Cancer Cells to the HSP90 Inhibitor AUY922." Oncotarget 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.